RESOURCES FROM KACTUS
Article: Neoantigen-Based Immunotherapy: Unveiling Disease-Specific Targets
Neoantigen-based immunotherapy is revolutionizing cancer treatment by focusing on neoantigens—unique proteins formed by mutations in cancer cells. These neoantigens are distinct from normal tissue proteins, making them highly specific targets for immunotherapy. The importance of this approach lies in its precision, allowing for personalized treatment development. Applications include adaptive cell therapies, vaccines, and antibody-based therapies, all designed to harness the body’s immune system to recognize and eliminate cancer cells with minimal impact on healthy tissues.
In this article, KACTUS discussed the significance of neoantigen in research on cell therapy and drug discovery, highlighted various methods for neoantigen identification, as well as introducing tools for neopeptide identification and validation. Read more.
*All products listed on this site and sold through LAB-A-PORTER Limited are for research use only (RUO). Not for human use. Not for therapeutic or diagnostic use.
OUR TOP PRODUCT PICKS
Biotinylated Human Peptide Ready HLA-A*02:01&B2M Monomer-Protein (MHC-HM43RB)
Human Peptide Ready HLA-A*02:01&B2M Monomer-Protein (MHC-HM43R)
Biotinylated Human Peptide Ready HLA-A*11:01&B2M Monomer-Protein (MHC-HM41RB)
Biotinylated Human Peptide Ready HLA-E*01:03&B2M Monomer-Protein (MHC-HM42RB)
Biotinylated Human Peptide Ready HLA-A*03:01&B2M Monomer-Protein (MHC-HM44RB)
Human Peptide Ready HLA-A*03:01&B2M Monomer-Protein (MHC-HM44R)
PE-Labeled Human Peptide Ready HLA-A*03:01&B2M Tetramer Protein (MHC-HM44RTP)
Explore more on the full product offerings on peptide-ready MHCs (prMHC).
*All products listed on this site and sold through LAB-A-PORTER Limited are for research use only (RUO). Not for human use. Not for therapeutic or diagnostic use.
ABOUT KACTUS
Provides quality recombinant proteins and enzymes that accelerate therapeutic development
Founded in 2018, KACTUS is a leading manufacturer of recombinant proteins and enzymes, providing both off-the-shelf products and custom protein services. Their extensive catalog includes over 3,000 recombinant proteins, featuring antibody drug targets, cytokines, transmembrane proteins, MHC monomers and tetramers, immune checkpoint proteins, biotinylated proteins, and more. They also offer AAV titration ELISA kits, GMP-grade gene editing enzymes, and other GMP enzymes. All their products undergo rigorous testing for purity and bioactivity to ensure quality performance and consistency. KACTUS is ISO 13485:2016 certified and operates state-of-the-art facilities, including a 10,000 sq. meter GMP-grade manufacturing site.